Treatment of Recurrent Boils in Children with Partial Antibiotic Response
For children with recurrent boils (furuncles) on the face and body that partially respond to antibiotics, incision and drainage is the primary treatment, with antibiotics reserved for specific indications including systemic signs of infection, facial location (difficult to drain completely), multiple sites, or failure to respond to drainage alone. 1
Initial Management Approach
Incision and Drainage as Primary Treatment
- Incision and drainage is the recommended treatment for furuncles and carbuncles, regardless of antibiotic use 1
- Simple boils often require drainage alone without antibiotics 1
- The procedure should be aggressive enough to ensure complete drainage 1
When to Add Antibiotics After Drainage
Antibiotic therapy is specifically indicated when any of the following are present 1:
- Systemic inflammatory response syndrome (SIRS): fever >38°C or <36°C, tachycardia >90 bpm, tachypnea >24 breaths/min, or white blood cell count >12,000 or <4,000 cells/µL 1
- Facial location: boils on the face are difficult to drain completely and warrant antibiotic coverage 1
- Multiple sites of infection or rapid progression with associated cellulitis 1
- Extremes of age (very young children) 1
- Lack of response to incision and drainage alone 1
- Associated comorbidities or immunosuppression 1
Antibiotic Selection for Pediatric Patients
First-Line Oral Antibiotics for CA-MRSA Coverage
Since the partial response suggests possible community-acquired MRSA (CA-MRSA), empiric coverage should target this pathogen 1:
Clindamycin: 10-13 mg/kg/dose PO every 6-8 hours, not to exceed 40 mg/kg/day 1
Trimethoprim-sulfamethoxazole (TMP-SMX): 4-6 mg/kg/dose (trimethoprim component) PO every 12 hours 1
Doxycycline (for children ≥8 years): <45 kg: 2 mg/kg/dose PO every 12 hours 1
- Not recommended for children under 8 years due to tooth discoloration risk 1
Duration of Treatment
- 5 to 10 days of antibiotic therapy is recommended, individualized based on clinical response 1
- Treatment duration should be guided by resolution of inflammation and systemic symptoms 1
Management of Recurrent Infections
Culture and Sensitivity Testing
- Culture recurrent abscesses early in the course to guide antibiotic selection 1
- Gram stain and culture of pus from carbuncles and abscesses are recommended 1
- Treatment with a 5- to 10-day course of an antibiotic active against the isolated pathogen 1
Decolonization Protocol for Recurrent S. aureus
Consider a 5-day decolonization regimen for recurrent S. aureus infections 1:
- Intranasal mupirocin twice daily 1
- Daily chlorhexidine washes 1
- Daily decontamination of personal items (towels, sheets, clothes) 1
Evaluation for Underlying Causes
- Search for local causes such as pilonidal cyst, hidradenitis suppurativa, or foreign material at sites of recurrent infection 1
- Evaluate for neutrophil disorders if recurrent abscesses began in early childhood 1
Common Pitfalls to Avoid
Antibiotic Monotherapy Without Drainage
- Never rely on antibiotics alone for boils that require drainage—this leads to treatment failure 1
- The "partial response" to antibiotics likely reflects inadequate source control rather than antibiotic resistance 1
Inappropriate Antibiotic Selection
- Avoid using rifampin as monotherapy or adjunctive therapy for skin infections—resistance develops rapidly and there is no proven benefit 1
- Do not use TMP-SMX alone if streptococcal infection is suspected, as it lacks reliable activity against β-hemolytic streptococci 1
Facial Lesions Require Special Consideration
- Facial boils warrant antibiotic therapy even after drainage due to difficulty achieving complete drainage and risk of complications 1
- Consider more aggressive management for facial lesions given cosmetic and safety concerns 1
When to Consider Hospitalization
Inpatient management with intravenous antibiotics is indicated for 1:
- Systemic toxicity despite appropriate oral antibiotics
- Rapidly progressive or worsening infection
- Associated septic phlebitis
- Inability to achieve adequate source control
For severe infections requiring IV therapy, vancomycin remains the treatment of choice for MRSA, with clindamycin as an alternative 1, 2